All articles by
Helix SARS-CoV-2 test with a locker system receives FDA Emergency Use Authorization (EUA)
Helix, a nationwide leader in population genomics, COVID-19 diagnostic testing and viral surveillance, has received FDA Emergency Use Authorization (EUA)…
GE Healthcare secures FDA approval for general anaesthesia delivery software
GE Healthcare, the healthcare arm of General Electric (GE), launched the software in Europe in 2010. With the latest approval,…
Bioventus exercises call option to buy remaining stake in CartiHeal
Orthopaedic therapies and diagnostic tools developer Bioventus announced that it has exercised its call option to buy the remaining stake…
FEops wins FDA nod for preoperative planning solution HEARTguide
FEops has secured the US Food and Drug Administration (FDA) 510(k) approval for its cloud-based procedure planning solution HEARTguide. The…
Olympus announces exclusive U.S. distribution agreement with EndoClot Plus
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced today a strategic…
NHS unveils bedside genetic test to save babies from permanent deafness
The National Health Service (NHS), the publicly funded healthcare system in England, has launched a new bedside genetic test, dubbed…
bioLytical wins Health Canada approval for iStatis COVID-19 antigen test
Canada-based diagnostic devices manufacturer bioLytical Laboratories has secured Health Canada approval for the launch of its iStatis COVID-19 Antigen Home…
Venus Concept submits FDA 510(k) related to the use of its Aime next generation robotic technology for tissue excision and skin resurfacing
Venus Concept, a global medical aesthetic technology leader, today announced it has submitted a 510(k) premarket notification (“510(k)”) to the…
Fresenius Kabi announces two deals to bolster position in biosimilars and medtech
German injectable medicines specialist Fresenius Kabi announced two acquisitions to bolster its position in biosimilars and medical technology sectors. The…
UoH start-up ReaGene Innovations licenses Covid diagnostics to Lay Science
Indian healthcare start-up ReaGene Innovations has licensed its newly developed ELISA and FAST FLOW SPOT diagnostic tests to US-based Lay…